The Novo Nordisk Network for Healthy Populations (NHP) is pleased to launch the Evidence-to-Impact Grant, a funding opportunity supporting multidisciplinary, community-engaged research teams to generate actionable evidence that can inform policies, programs, health services and other population-level approaches to reducing the burden of type 2 diabetes and related cardiometabolic conditions.
Projects must address at least one of three research streams: Better Care — Health Care Systems and Services; Lower Risk — Health Behaviours and Communities; or Healthier Environments — Built Environments and Urban Policy.
Funding of up to $100,000 is available for projects lasting 12–24 months. Applications are due December 11, 2026.